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In Taxus plants the biosynthesis of the pharmaceu-
tical paclitaxel includes the transfer of b-amino phe-
nylpropanoyls from coenzyme A to the diterpenoid
baccatin III by an acyl CoA-dependent acyltrans-
ferase. Several enzymes on the pathway are known,
yet a few remain unidentified, including the putative
ligase that biosynthesizes key b-amino phenylpropa-
noyl CoAs. The multienzyme, nonribosomal peptide
synthetase that produces tyrocidines contains a tri-
domain starter module tyrocidine synthetase A that
normally activates (S)-a-Phe to an adenylate anhy-
dride in the adenylation domain. The Phe moiety is
then thioesterified by the pendent pantetheine of
the adjacent thiolation domain. Herein, the adenyla-
tion domain was found to function as a CoA ligase,
making a-, b-phenylalanyl, and phenylisoserinyl
CoA. The latter two are substrates of a phenylpropa-
noyltransferase on the biosynthetic pathway of the
antimitotic paclitaxel.
INTRODUCTION
Currently, Taxus plant cell fermentation (PCF) is used to mass-
produce the antimitotic paclitaxel (Taxol) and related precursors
(Mountford, 2010). PCF replaced a semisynthetic method that
employed (1) a synthetic phenylisoserine (PheIso) precursor
(a b-lactam made via a multistep process) to add a phenyliso-
serinyl (PheIso-yl) moiety to the C13-hydroxyl group of baccatin
III, (2) compulsory protecting group steps, and (3) voluminous
hazardous solvents and toxic reagents for the large-scale
production of paclitaxel (Figure 1A) (Mountford, 2010).
The semisynthetic method to produce the drug was consid-
ered environmentally harmful; however, its production yields
were superior to the low yields of paclitaxel in Taxus cell cultures,
likely caused by divergent, competitive metabolic pathways and
rate-limiting biosynthetic steps in vivo. Among several known
Taxus enzymes, the late-stage CoA thioester-dependent 13-O-
phenylpropanoyltransferase and the N-benzoyltransferase have
been characterized (Figure 1B) (Jennewein et al., 2004). These
enzymes catalyze regioselective phenylpropanoylation at theChemistry & Biology 19,C13-hydroxyl of baccatin III and N-benzoylation of the PheIso-
yl side chain, respectively. Application of the phenylpropanoyl-
transferase provides a potential method to biocatalytically attach
a free b-amino acid side chain (i.e., without protecting groups) to
the baccatin III core and circumvent the extra steps and
hazardous solvents of the semisynthetic route.
The phenylpropanoyltransferase was earlier characterized, in
part, with amino phenylpropanoyl (AmPheprop-yl) CoA sub-
strates that were synthesized using a mixed anhydride and CoA
(Jennewein et al., 2004). The amino acid precursors, however,
requiredprotection at their aminogroupsbefore synthetic thioes-
terification. Reagent-based synthesis of b-AmPheprop-yl CoA
thioesters is a major limitation toward converting baccatin III to
paclitaxel in a completely biosynthetic approach in vitro. The pro-
tecting group chemistry can plausibly be avoided by employing
a chemoselective carboxylate CoA ligase (CL). In this study the
adenylation (A) domain (i.e., PheA) of the nonribosomal peptide
synthetase (NRPS) tyrocidine synthetase A (TycA, Genbank
accession number X13237) was examined as a potential
b-AmPheprop-yl CL. PheA ordinarily uses ATP and Mg2+ to acti-
vate (S)-a-phenylalanine ((S)-a-Phe) to a phosphoric acid-AMP
anhydride. The phenylalanyl (Phe-yl) moiety is then transferred
to the mercapto group of 40-phosphopantetheine (Ppant) of the
bordering thiolation (T) domain, with release of AMP (Figure 2A).
The epimerization (E) domain then changes the stereochemistry
of thependent (S)-a-Phe to the (R)-enantiomer,whichprogresses
through synthetase modules TycB and TycC to produce tyroci-
dines A–D in Bacillus brevis (Villiers and Hollfelder, 2009).
The acyl-adenylate activation in the starter domains of TycA
and other NRPS and hybrid polyketide synthetase (PKS)/
NRPS multienzymes is similar to carboxylate activation to CoA
thioesters by CLs, which are also dependent on ATP and Mg2+
(Kaneko et al., 2003). The mechanistic similarity of CLs and the
A-domains of NRPS and PKS/NRPSwas supported by an earlier
study by Ehmann et al. (2000), showing that the A-domain of the
EntE module on the enterobactin NRPS pathway in Escherichia
coli used CoA and pantetheine as surrogates for the Ppant arm
of a downstream T-domain. The thioesterification reaction
involving an A-domain and thiols, shown previously, provided
motivation for the current study to assess if TycA could also react
as a small molecule thiol ligase. Herein, TycAwas shown tomake
a- and b-Phe-yl and (2R,3S)-PheIso-yl CoA and S-(N-acetylcys-
teamine) (SNAC) thioesters from the corresponding amino acids,
CoA, and NAC, respectively. The heterologous expression,679–685, June 22, 2012 ª2012 Elsevier Ltd All rights reserved 679
Figure 1. Production of Paclitaxel
(A) Semisynthetic route to paclitaxel.
(B) Proposed biosynthetic pathway to paclitaxel, showing key acylation steps: (i) 5-O-acetylation by a taxadien-5a-ol acetyltransferase; (ii) several oxidation
reactions; (iii) 2-O-benzoylation by a 2-O-debenzoylbaccatin III benzoyltransferase; (iv) 10-O-acetylation by a 10-deacetylbaccatin III acetyltransferase; and (v)
13-O-acylation by a phenylpropanoyltransferase (biosynthesis of CoA thioester substrates is described herein) followed by N-benzoylation by an N-benzoyl-
transferase. Ac, acetyl; Ph, phenyl; TES, triethylsilyl.
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ligase are described.
RESULTS AND DISCUSSION
Expression and Purification of the ATE Tridomain of
Wild-type and Mutant TycA
The tycA cDNA encoding the A-, T-, and E-domains was heterolo-
gously expressed as a C-terminal His6 fusion in E. coliBL21(DE3).
Because E. coli BL21 naturally encodes the 40-Ppant transferase
enzyme (Jeong et al., 2009), Ser563 of TycA was changed to
Ala (TycA-S563A) to prevent Ppant coupling at Ser563 of the
T-domain. This mutation would thus allow access of an exoge-
nous thiol to the acyl-adenylate intermediate of TycA-S563A
without competition from the Ppant. The mutant clone was ex-
pressed the same as tycA. Each solubly expressed enzyme was
isolated, Ni-affinity purified to 95% for use in the activity assays.
Preliminary Assessment of TycA and TycA-S563A Thiol
Ligase Activities
Three AmPheprop substrates were added separately to reaction
mixtures containing overexpressed TycA or TycA-S563A, ATP,680 Chemistry & Biology 19, 679–685, June 22, 2012 ª2012 ElsevierMgCl2, and CoA or NAC. Liquid chromatography-electrospray
ionization tandemmass spectrometry (LC-ESI-MS/MS) analyses
of the biosynthetic products made in the assays incubated with
CoA showed that diagnostic [M  H] ions that were consistent
with the values calculated for a- and b-Phe-yl (m/z 913, eluting at
2.67 and 2.47 min, respectively) and (2R,3S)-PheIso-yl CoA
(m/z 929, eluting at 2.26 min) (see Figure S1 available online).
Collision-induced dissociation of the molecular ions confirmed
the identity of each CoA thioester. Control assays lacking either
enzyme, AmPheprop, ATP, or CoA from the appropriate enzyme
assay mixture did not yield a detectable [M  H] ion that
matched any of the corresponding AmPheprop-yl CoAs (Fig-
ure S1). Thus, the CL function of the catalysts was verified
(Figure 2A).
LC-ESI-MS/MS analysis of the products made in assays incu-
bated with NAC instead of CoA revealed fragment ions of the
[M + H]+ ion that were consistent with a- or b-Phe-yl (m/z 267,
eluting at 4.49 and 3.01 min, respectively) and PheIso-yl SNAC
(m/z 283, eluting at 2.32 min). The MS data for each biosynthetic
SNACmatched those of authentic standards (Figure S1). Control
assays that lacked either enzyme, AmPheprop, ATP, or NAC did
not yield a detectable molecular ion consistent with the identityLtd All rights reserved
Figure 2. TycA Catalysis
(A) (i) TycA, ATP, Mg2+, (ii) TycA-catalyzed nucleophilic thioesterification of an AmPheprop by either the pantetheinyl-40-phosphatidyl moiety of the TycA
T-domain on the natural reaction pathway, CoA, or NAC. Base, putative basic residue of TycA; T-domain, T-domain of the TycA module (see also Figure S1).
(B) Kinetic model for CoA thioesterification reaction catalyzed by TycA and TycA-S563A.
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of the AmPheprop-yl side chain of the CoA and SNAC thioesters
was not evaluated; thus, the effect of the E-domain on the
stereogenic centers currently remains unknown.
Kinetic Analyses of TycA and TycA-S563A as Thiol
Ligases
The kinetic parameters of TycA and TycA-S563A were calcu-
lated by separately incubating each catalyst with various
dilutions of an AmPheprop along with CoA or NAC and cofactors
at apparent saturation. The resulting acyl CoA and SNAC thio-
esters were quantified by liquid chromatography-electrospray
ionization-multiple reaction monitoring (LC-ESI-MRM).
Kinetics with CoA
The catalytic efficiency of TycA for (R)-b-Phe was 5- and 10-fold
higher than for (S)-a-Phe and (2R,3S)-PheIso, respectively. The
KM values of TycA (Table 1) suggested a preference for the a-
or b-Phe substrate, with a Ca- or Cb-NH2 group, respectively,
but not for PheIso, with Ca-OH and Cb-NH2 groups. The stereo-
chemistry of the Cb-NH2 of (2R,3S)-PheIso is oriented identically
to the amino group of (R)-b-Phe; thus, the Ca-OH was consid-
ered responsible for affecting the catalysis by sterics, electronic
effects, or H-bonding interactions.Chemistry & Biology 19,The catalytic efficiency of TycA-S563A for (R)-b-Phe was
highest and followed a similar trend to that of TycA (Table 1). In
general the catalytic efficiency of TycA did not vary more than
3-fold over that of TycA-S563A, suggesting that the con-
centration of CoA at 1 mM offset the pantetheinylation reaction
with the likely small fraction of TycA holoenzyme, containing
the Ppant at the T-domain. Thus, CoA likely attacked the
AmPheprop-yl AMP anhydride while it remained docked in the
A-domain of TycA (Figure 2B). At this point, the fraction of
AMP anhydride that reacted with CoA, after it was released
into the medium, could not be determined. TycA was therefore
deemed operationally similar to TycA-S563A at high concentra-
tions of CoA.
The kinetic parameters of the enzymes were also calculated
with a dilution series of CoA and 1 mM (S)-a-Phe. The resulting
thioester product was quantified by LC-ESI-MRM, as before,
and the kCoAcat /KM value of the TycA congeners for CoA was
at a similar order of magnitude (Table 1). However, the differ-
ence in catalytic efficiency between each enzyme was largely
influenced by the 2.5-fold higher KM of TycA, yet similar
kCoAcat , compared to that of TycA-S563A (Table 1). The higher
KM of TycA could suggest competition between CoA, at low
concentration, and a small amount of covalent Ppant at the
T-domain.679–685, June 22, 2012 ª2012 Elsevier Ltd All rights reserved 681
Table 1. Steady-State Kinetic Analysis of the TycA and TycA-S563A
TycA
Substrate KM (mM) k
CoA
cat (min
1) kCoAcat /KM (s
1 , M1) kATPcat (min
1) kATPcat /KM (s
1 , M1)
(S)-a-Phe 41.9 ± 2.0 0.25 ± 0.01 99.4 ± 6.2 0.13 ± 0.01 51.7 ± 1.7
(R)-b-Phe 50.6 ± 7.9 1.6 ± 0.3 527 ± 129 0.10 ± 0.01 32.9 ± 0.14
(2R,3S)-PheIso 89.3 ± 15.0 0.25 ± 0.02 46.7 ± 8.7 b b
CoAa 1,976 ± 175 0.75 ± 0.05 6.3 ± 0.7 – –
TycA-S563A
(S)-a-Phe 33.9 ± 4.0 0.69 ± 0.08 339 ± 56 0.09 ± 0.01 44.2 ± 0.2
(R)-b-Phe 62.3 ± 1.0 3.00 ± 0.04 803 ± 17 0.06 ± 0.01 16.1 ± 1.2
(2R,3S)-PheIso 191 ± 10 0.43 ± 0.01 37.5 ± 2.1 b b
CoAa 804 ± 26 0.90 ± 0.08 18.7 ± 1.8 – –
TycA with NAC
Substrate KM (mM) k
NAC
cat (min
1) kNACcat /KM (s
1 , M1)
(S)-a-Phe 27.0 ± 6.5 0.05 ± <0.01 30.8 ± 9.7
(R)-b-Phe 30.4 ± 3.9 0.36 ± 0.06 197 ± 42
(2R,3S)-PheIso 132 ± 56 0.19 ± 0.01 24.0 ± 10.3
NACa 153 ± 22 0.09 ± <0.01 9.8 ± 1.8
TycA-S563A with NAC
(S)-a-Phe 37.8 ± 1.6 0.20 ± 0.002 88.1 ± 3.8
(R)-b-Phe 58.9 ± 6.4 0.024 ± 0.001 6.8 ± 0.8
(2R,3S)-PheIso 512 ± 43 0.31 ± 0.05 10.1 ± 1.8
NACa 268 ± 4 0.10 ± <0.01 6.2 ± 0.6
aKinetic measurements for CoA or NAC determined with (S)-a-Phe as cosubstrate. All values are expressed as mean ± SDs of triplicates.
bPheIso-yl AMP was below the limits of detection. kCoAcat , k
NAC
cat , and k
ATP
cat are turnover in the presence of CoA, NAC, and ATP at apparent saturation,
respectively.
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The syntheses of authentic AmPheprop-yl AMPs (Owczarek
et al., 2008) for use as quantitation standards were low yielding;
therefore, the biosynthetic acyl AMPs were quantified by LC-
ESI-MRM (see Supplemental Experimental Procedures) for
kinetic analyses. The kATPcat /KM value of TycA for the conversion
of a-Phe and b-Phe (ATP at apparent saturation; cf. Figure S1)
to a-Phe-yl and b-Phe-yl AMP was 2- and 15-fold lower,
respectively, than the kCoAcat /KM values for the conversion of a-
and b-Phe to the corresponding AmPheprop-yl CoAs (Table 1).
Similarly, the kATPcat /KM value of TycA-S563A was 7- and
46-fold lower, respectively, for the conversion of the same
substrates to their AMP anhydrides than the kCoAcat /KM for the
conversion to the corresponding CoA thioesters. PheIso-yl
AMP was below the limits of detection in similar assays. The
slower steady-state production rate of the AmPheprop-yl AMPs
detected in solution did not account for the production rate of the
corresponding AmPheprop-yl CoAs (Table 1). The greater cata-
lytic efficiency for CoA thioester production over AmPheprop-yl
AMP biosynthesis confirmed that CoA displaced AMP from the
AmPheprop-yl AMP in complex with TycA, at steady state, and
not from the acyl AMP intermediate in solution to form the
thioesters.
Kinetics with NAC
The kNACcat and KM values of TycA or TycA-S563A for NAC
were obtained by incubating the thiol separately with each
AmPheprop under standard ligase conditions. The reaction682 Chemistry & Biology 19, 679–685, June 22, 2012 ª2012 Elsevierproducts were identified and quantified by LC-ESI-MRM by
comparison to the retention time and fragment transition ions
of authentic standards. The efficiency of TycA (with NAC) was
highest for (R)-b-Phe, followed by (S)-a-Phe, and then by
(2R,3S)-PheIso. This trend was similar (but at lower values) to
when CoA was used in place of NAC (Table 1). The KM values
of TycA for each AmPheprop substrate with NAC at apparent
saturation were different but approximately the same order of
magnitude as when CoA was used. This suggested that the
smaller NAC thiol did not affect binding of the AmPheprop to
the PheA domain (Table 1). The kNACcat /KM of TycA for each
AmPheprop and NAC ranged between 1.5- and 3-fold lower
than when CoA was used, suggesting that CoA is more catalyt-
ically competent than NAC, as anticipated.
The catalytic efficiency of TycA-S563A (compared with TycA)
was lower for (R)-b-Phe and (2R,3S)-PheIso when NAC was the
cosubstrate but increased for the natural substrate (S)-a-Phe.
This strayed from the trend where the catalytic efficiency of
TycA-S563A was highest for b-Phe, as in the other assay groups
(Table 1). A 15-fold decrease in turnover and an2-fold increase
in KM caused an 30-fold lower catalytic efficiency of TycA-
S563A compared to that of TycA for (R)-b-Phe (Table 1). Appar-
ently, an as yet unknown interaction between NAC, b-Phe,
and/or the catalyst affected the turnover. Interestingly, the KM
values of both TycA and TycA-S563A for NAC were lower than
for CoA (Table 1), despite CoA being a better mimic of the natural
Ppant used in the normal TycA reaction (Figure 2A). It is unclear
whether the smaller NAC has greater reach to the TycA activeLtd All rights reserved








Propionyl-CL Propionate 20 1,980 1.65 3 106
CoA 215 2,520 1.95 3 105
Benzoate-CL Benzoate 11 26,000 3.94 3 107
CoA 100 NL NL
Phenylacetate-CL Phenylacetate 6,100 84 230
CoA 940 NL NL
Cinnamate-CL Cinnamate 190 28.5 2,500
CoA NL NL NL
4-Cl-Benzoate-CL 4-Cl-benzoate 0.9 552 1.02 3 107
CoA 310 558 3.00 3 104
NL, no listing.
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chemistry.
Comparing the Kinetic Parameters of TycA/TycA-S563A
to Other CLs
Compared to the KM values of bacterial CLs for CoA (100–
940 mM) and acyl substrates (10–6,000 mM), those of TycA and
TycA-S563A for CoA (1,976 and 804 mM, respectively) are about
the same order of magnitude, whereas the acyl substrates
(34–132 mM) are more variable (Tables 1 and 2). CLs on catabolic
pathways in various bacteria convert, for example, propionate
(Horswill and Escalante-Semerena, 2002), benzoate (Altensch-
midt et al., 1991), and 4-chlorobenzoate (Wu et al., 2009) to
their corresponding CoA thioesters with superior catalytic effi-
ciency (1.653 106, 3.943 107, and 1.023 107 s1,M1, respec-
tively) compared to those on secondary metabolic pathways
(%2,500 s1,M1), such as for TycA (used in tyrocidines A–D
biosynthesis, described here as a CL), phenylacetate CL from
Penicillium chrysogenum (Koetsier et al., 2009), penicillin G
biosynthesis, and cinnamate CL from Streptomyces coelicolor
(Kaneko et al., 2003). The role of cinnamoyl CoA is as yet
undefined; however, it may play a role in biosynthesis because
Streptomyces sp. are known to produce a variety of secondary
products (Ohnishi et al., 2008). Notably, a recent report described
a mutation of phenylacetate CL from P. chrysogenum that
reduced the KM for b-Phe from low mM amount to 68 mM in the
reaction to make b-Phe-yl CoA (Koetsier et al., 2009). Likewise,
the kCoAcat /KMof TycA,which already usesAmPheprop substrates,
may potentially be enhanced through mutagenesis by removing
the T- and E-domains to resolve the CL activity of the A-domain.
Conclusions
Under CL assay conditions, TycA (and TycA-S563A) converted
b-aryl a- and b-amino acids to their CoA and SNAC thioesters,
via enzyme-bound adenylate intermediates, kinetically similar
to CLs involved in secondary metabolism. The b-Phe-yl and
PheIso-yl CoAs made here are on the biosynthetic pathway of
the paclitaxel and, thus, can potentially be used to make the
antineoplastic drug. The SNAC thioesters of each amino acid
were biosynthesized when NAC was used as the thiol donor.
This property may facilitate the current synthetic methods toChemistry & Biology 19,make acyl SNAC thioester surrogates that are used to interro-
gate the specificity of NRPS catalysts (Lautru and Challis,
2004) and PKS-catalyzed pathways (Harmrolfs et al., 2010).
The small molecule thiol ligase activity of TycA provides a
platform on which to further examine the substrate specificity
of the catalyst with other arylalanine and arylisoserine sub-
strates. In addition the findings herein encourage the probe of
other A-domains within modules on different NRPS enzymes
(Meier and Burkart, 2011) for similar ligase activity.
SIGNIFICANCE
Presented here, TycA is shown to produce PheIso-yl CoA,
which is an essential precursor to begin developing in vitro
or in vivo biocatalytic methods to produce paclitaxel that
is currently in short supply (FDA, 2012). Furthermore, the
AMP, CoA, and NAC ligase reactions provide insights into
the mechanism of the PheA domain and build on its existing
substrate selectivity. The loading modules of other NRPS
multienzymes may also be able to biosynthesize nonnatural
acyl thioesters and thus bypass protecting group steps, if
needed, for their total synthesis.
EXPERIMENTAL PROCEDURES
Assessing TycA and TycA-S563A as CLs
Each AmPheprop substrate (at 1 mM) was separately incubated at 31C in
single stopped-time (1 hr) reactions containing 100 mM HEPES (pH 8.0),
ATP (1 mM), MgCl2 (3 mM), CoA (1 mM), and TycA or TycA-S563A (100 mg).
Various control reactions were carried out in parallel where TycA, TycA-
S563A, ATP, or CoA was omitted. The reactions were acid quenched (pH
2 with 10% formic acid in distilled water) and lyophilized to dryness. The
resultant samples were separately dissolved in aqueous 0.01 M HCl (100 ml)
and analyzed using a Quattro-Premier Electrospray Tandem Mass Spec-
trometer coupled with Acquity UPLC system (LC-QP/ESI-MS/MS) fitted with
a reverse-phase Halo C18 column (5 cm 3 2.1 mm) at 30C. An aliquot
(10 ml) of each sample was loaded onto the column, and the analytes were
eluted with a solvent gradient (designated as the CoA-Elution Gradient) of
acetonitrile (Solvent A) in 0.05% triethylamine in distilled water (Solvent B)
(held at 2.5% Solvent A for 3.17 min, increased to 100% Solvent A over 5 s
with a 2 min hold, and then returned to 2.5% Solvent A over 5 s with a 6 min
hold) at a flow rate of 0.4 ml/min. The effluent from the column was directed
to the mass spectrometer set to negative ion mode with a scan range of m/z
200–1,000 atomic mass units.
Kinetics of the CL Reaction
After identifying productive AmPheprop substrates for both enzymes in the CL
assays, each substrate (at 1 mM) was separately incubated (31C) in 100 ml
reactions containing 100 mM HEPES (pH 8.0), ATP (1 mM), MgCl2 (3 mM),
CoA (1 mM), and TycA or TycA-S563A (20 mg/ml) to establish steady-state
conditions relative to protein concentration and time. Under steady-state
conditions each substrate, at ten concentration intervals from 5 to 1,000 mM
(in duplicate), was separately incubated with TycA or TycA-S563A (20 mg in
0.1 ml reactions) for 30 min. The reactions were acid quenched, as before,
and acetyl CoA (1 mM) was added as the internal standard to each sample.
The biosynthetic products were quantified by LC-ESI-MRM mass spec-
trometry (Anderson and Hunter, 2006) on the LC-QP/ESI-MS/MS fitted with
a C18 Ascentis Express column (2.5 3 50 mm, 2.7 mm) at 30C. An aliquot
(5 ml) of each sample was loaded onto the column, and the analytes were
eluted with the CoA-Elution Gradient. The effluent from the chromatography
column was directed to the mass spectrometer where the first quadrupole
mass analyzer (in negative ion mode) was set to select for the molecular ion
of a biosynthesized acyl CoA product. The selected ion was then directed to
a collision gas chamber where the collision energy was optimized to maximize679–685, June 22, 2012 ª2012 Elsevier Ltd All rights reserved 683
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acyl CoAs) resolved in the second quadrupole mass analyzer by MRM.
Authentic benzoyl CoA was used to verify the diagnostic ion transition
[M  H] / m/z 408. The peak area of ion m/z 408 for each biosynthetic
AmPheprop-yl CoA thioester was converted to concentration units using linear
regression of a dilution series of authentic CoA (at 12 intervals from 0.05 to
100 mM) plotted against the corresponding ion abundance. The initial velocity
(vo) of AmPheprop-yl CoA production was used to calculate KM and k
CoA
cat
according to the Michaelis-Menten equation (R2 was typically between 0.90
and 0.99).
The KM values were assessed by incubating each enzyme with (S)-a-Phe
(1 mM), MgCl2 (3 mM), ATP (1 mM), and CoA (starting at 0.05 mM and
increasing in 2-fold intervals up to 25.6 mM) at 31C for 30 min. The reactions
were acid quenched, as before, and acetyl CoA (1 mM) was added as the
internal standard. The biosynthetic products were quantified by LC-ESI-
MRM of ion m/z 408, derived from the CoA moiety of the thioester analytes,
as described herein. The vo of (S)-a-Phe-yl CoA production in each assay
was used to calculate KM and k
CoA
cat according to the Michaelis-Menten equa-
tion (R2 was typically between 0.92 and 0.98).
Assessing TycA and TycA-S563A as NAC Ligases
Similar experiments were done as described above in the CL screen, except
that NAC (5 mM) was used in place of CoA with the AmPheprop substrates
in different 0.1 ml assays. The enzyme assays contained 100 mM HEPES
(pH 8.0), AmPheprop (1 mM), ATP (1 mM), MgCl2 (3 mM), NAC (5 mM), and
TycA or TycA-S563A (100 mg), and were incubated at 31C for 1 hr. Various
control reactions were carried out in parallel where TycA, TycA-S563A, ATP,
or CoA was omitted from the assay. The reactions were acid quenched (pH
2 with 6MHCl) and lyophilized to dryness. The resultant residues were sepa-
rately dissolved in aqueous 0.01 M HCl (100 ml). An aliquot (10 ml) of each
sample was analyzed on a quadrupole time-of-flight tandem mass spec-
trometer coupled with a 2795 HPLC system (LC-QToF-MS/MS) fitted with
a reverse-phaseHalo C18 column (5 cm3 2.1mm) at 30C. Themass analyzer
was set to positive ion mode, with a scan range of m/z 0–500 atomic mass
units. The analytes were eluted from the columnwith a solvent gradient (desig-
nated as the SNAC-Elution Gradient) of 0%–15% of acetonitrile (Solvent A) in
0.1% formic acid in distilled water (Solvent B) at a flow rate of 0.2 ml/min.
Kinetics of the NAC Ligase Reaction
AmPheprops (each at 1 mM) were separately incubated with TycA or TycA-
S563A (20 mg) in the presence of NAC (1 mM), ATP (1 mM), and MgCl2
(3 mM) to establish steady-state conditions relative to protein concentration
and time at 31C. Under steady-state conditions each AmPheprop substrate,
at ten intervals from 5 to 2,000 mM (in duplicate), was separately incubated with
TycA or TycA-S563A (20 mg), ATP (1 mM), MgCl2 (3 mM), and NAC (1 mM) in
duplicate, single stopped-time (30 min) 100 ml assays. The reactions were
acid quenched, as before, and (N-Boc)-a-Phe-yl SNAC (1 mM) was added as
an internal standard when (S)-a-Phe and (2R,3S)-PheIso were used as
substrates, and racemic (N-Boc)-b-Phe-yl SNAC was added when (R)-b-Phe
was the substrate (Supplemental Experimental Procedures). The samples
were analyzed on the LC-QP/ESI-MS/MS fitted with a C18 Ascentis Express
column (2.5 3 50 mm, 2.7 mm) at 30C. An aliquot (5 ml) of each sample was
loaded onto the column, and the analytes were eluted with the CoA-Elution
Gradient, described earlier. In brief the effluent from the chromatography
column was directed to the mass spectrometer, in MRM scan mode, to quan-
tify the biosynthetic acyl SNAC products. The transition ions derived from the
correspondingmolecular ions werem/z 120, 131, and 106 for a-, b-Phe-yl, and
PheIso-yl SNAC, respectively. A standard curve was used to convert the peak
area of the monitored fragment ion to concentration units for each biosyn-
thetic phenylpropionyl SNAC. Authentic (S)-a-, (R/S)-b-Phe-yl, and (2R,3S)-
PheIso-yl SNAC (see Supplemental Experimental Procedures) were used to
construct the linear regression of the peak area of the monitored ion plotted
against concentration of the authentic standard, at 12 intervals from 0.16 to
320 mM (in triplicate). The vo of a-, b-Phe-yl, and PheIso-yl SNAC production
in each corresponding assay was used to separately calculate KM and k
NAC
cat
for each substrate according to the Michaelis-Menten equation (R2 = 0.99).
The KM values of TycA and TycA-S563A for NAC were assessed by incu-
bating each enzyme separately with (S)-a-Phe (1 mM), MgCl2 (3 mM), ATP684 Chemistry & Biology 19, 679–685, June 22, 2012 ª2012 Elsevier(1 mM), and NAC at ten intervals from 5 to 2,000 mM (in triplicate) at 31C for
30 min. The reactions were acid quenched, as before, and internal standard
(N-Boc)-(S)-a-Phe-yl SNAC (1 mM) was added to each sample. The biosyn-
thetic SNAC thioesters were quantified by LC-ESI-MRM, and the monitored
fragment ion (m/z 120) derived from the a-Phe-yl moiety was quantified iden-
tically to the procedure described earlier in this section. The vo of (S)-a-Phe-yl
SNAC production in separate assayswas plotted against substrate concentra-
tion and fit according to the Michaelis-Menten equation (R2 was typically




Supplemental Information includes one figure, Supplemental Experimental
Procedures, and Supplemental References and can be found with this article
online at doi:10.1016/j.chembiol.2012.05.007.
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